Skip to main content
. 2008 Jul 29;467(12):3249–3256. doi: 10.1007/s11999-008-0405-2

Table 1.

Experimental design

Time (weeks) Assessment Experimental groups
Nondiabetic Diabetic
Sham surgery* Sham surgery* 0 μg OP-1 + carrier 25 μg OP-1 + carrier
2 Radiographic histologic 5 5 6 4
4 Radiographic histologic 6 6 4 6
Biomechanical 6 4 6 5

* Control animals in which closed fracture was created and fracture site was opened and then closed without treatment; OP-1 = osteogenic protein-1.